Glipizide Tablet, Extended Release
Product Images NDC 70518-3898

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-3898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This text is a description of a medication called glipiZIDE. It is a tablet with a strength of 5 mg, and the quantity provided is 90 tablets. The medication is meant to be protected from moisture and humidity. The text also includes information such as the medication being available by prescription only, the National Drug Code (NDC) number, and the expiration date and lot number. The source of the medication is mentioned as Aurohindo Pharma, located in Hyderabad, India. It is advised to keep this medication out of the reach of children. The text provides directions to refer to the package insert for usage instructions. The recommended storage temperature is between 20-25°C (58-77°F) with permissible excursions to 15.30°C (59-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA, with a contact number provided.*
FDA Label Image

Mm2 (Glipizide 5mg 70518 3898 01)

Mm2 (Glipizide 5mg 70518 3898 01)
FDA Label Image

Chemical Structure (Glipizide Str)

Chemical Structure (Glipizide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.